Category

News Brief

Atsena Therapeutics Raises $55 Million Series A Financing to Advance LCA1 Gene Therapy Clinical Program, Two Preclinical Assets, and Novel Capsid Development for Ocular Diseases

UF startup Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, announced it has closed an oversubscribed $55 million Series A financing led by Sofinnova Investments with participation from additional new investors Abingworth and Lightstone Ventures.

Tabrizian and Bhunia Develop Clandestine Wireless ID Tags

In a new paper published in Nature’s Microsystems and Nanoengineering, a team led by Dr. Roozbeh Tabrizian and Dr. Swarup Bhunia has demonstrated a novel product-labeling approach based on resonant nano-electro-mechanical systems (NEMS).

PanVent Emergency Ventilator Created to Fill Urgent Need During COVID-19

Dr. Samsun Lampotang has spent his career engineering solutions to medical problems. At the start of 2020, Lampotang’s focus was on designing, building and validating mixed reality guided intervention simulators to train physicians and nurses in medical procedures without putting patients at risk. But then COVID-19 changed all this.

Vanilla DNA Mystery Uncovered by UF/IFAS Research

University of Florida scientists have developed a tool to unlock the genetic traits that pinpoint the vanilla variety that produces an abundance of beans, grows efficiently and sustainably, with consumer-approved taste.

Pheronym and USDA Enter Into 5-Year CRADA

UF Innovate | The Hub and UF Innovate | Sid Martin Biotech alum Pheronym, an Ag-biotech pest control company, has signed a 5-year Cooperative Research and Development Agreement (CRADA) with the U.S. Department of Agriculture's Agricultural Research Service (USDA ARS).